title: [2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients].
abstract: The Standards, Options: Recommendations (SOR) project has been undertaken by the French National Federation of Cancer Centers (FNCLCC) is now part of the French National Cancer Institute. The project involves the development and updating of evidence-based Clinical Practice Guidelines (CPG) in oncology. In order to answer questions related to venous thromboembolic events(VTE) treatment and to central venous catheter thrombosis (CVCT) management in cancer patients, the SOR elaborated national guidelines, here presented in a short report. It results of a collaborative work with members from three learned societies("société nationale française de médicine interne": SNFMI, "société française de médicine vasculaire": SFMV and "société française dEanesthésie-réanimation:SFAR).
authors.forename: Isabelle
authors.initials: I
authors.lastname: Mahé
authors.forename: Ismail
authors.initials: I
authors.lastname: Elalamy
authors.forename: Dominique
authors.initials: D
authors.lastname: Farge-Bancel
authors.forename: Patrick
authors.initials: P
authors.lastname: Mismetti
authors.forename: Marie-Lorraine
authors.initials: ML
authors.lastname: Scrobohaci
authors.forename: Hamid
authors.initials: H
authors.lastname: Hocini
authors.forename: Guy
authors.initials: G
authors.lastname: Meyer
authors.forename: Diana
authors.initials: D
authors.lastname: Kassab-Chahmi
authors.forename: Lise
authors.initials: L
authors.lastname: Bosquet
authors.forename: Francis
authors.initials: F
authors.lastname: Cajfinger
authors.forename: Hélène
authors.initials: H
authors.lastname: Desmurs-Clavel
authors.forename: Eric
authors.initials: E
authors.lastname: Desruennes
authors.forename: Marie-Cécile
authors.initials: MC
authors.lastname: Douard
authors.forename: Antoine
authors.initials: A
authors.lastname: Elias
authors.forename: Claire
authors.initials: C
authors.lastname: Grange
authors.forename: Irène
authors.initials: I
authors.lastname: Kriegel
authors.forename: Grégoire
authors.initials: G
authors.lastname: Le Gal
authors.forename: Hervé
authors.initials: H
authors.lastname: Lévesque
authors.forename: Michel
authors.initials: M
authors.lastname: Pavic
authors.forename: Jean Marc
authors.initials: JM
authors.lastname: Renaudin
authors.forename: Isabelle
authors.initials: I
authors.lastname: Quéré
authors.forename: Philippe
authors.initials: P
authors.lastname: Debourdeau
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D002405:Catheterization, Central Venous / Q000009:adverse effects* / Q000379:methods; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*; D051437:Renal Insufficiency / Q000150:complications; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight